Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies

References

• Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ, Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58:RR-8 1 - 52; PMID: 19644442
   PubMedGoogle Scholar
• Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, et al, Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:RR-8 1 - 62; PMID: 20689501
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1128 - 32; PMID: 21866086
   PubMedGoogle Scholar
• Hodges GR, Davis JW, Lewis HD Jr., Whittier FC Jr., Siegel CD, Chin TD, Clark GM, Noble GR. Response to influenza A vaccine among high-risk patients. South Med J 1979; 72:29 - 32; http://dx.doi.org/10.1097/00007611-197901000-00010; PMID: 366766
   PubMed Web of Science ®Google Scholar
• Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ, Champlin RE, Aguilera EA, Tarrand JJ, Raad II. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 2006; 85:278 - 87; http://dx.doi.org/10.1097/01.md.0000232560.22098.4e; PMID: 16974212
   PubMed Web of Science ®Google Scholar
• Vidal L, Gafter-Gvili A, Leibovici L, Dreyling M, Ghielmini M, Hsu Schmitz SF, Cohen A, Shpilberg O. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst 2009; 101:248 - 55; http://dx.doi.org/10.1093/jnci/djn478; PMID: 19211444
   PubMed Web of Science ®Google Scholar
• Salles G, Seymour JF, Offner F, López-Guillermo A, Belada D, Xerri L, Feugier P, Bouabdallah R, Catalano JV, Brice P, et al. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. Lancet 2011; 377:42 - 51; http://dx.doi.org/10.1016/S0140-6736(10)62175-7; PMID: 21176949
   PubMed Web of Science ®Google Scholar
• Liu C, Schwartz BS, Vallabhaneni S, Nixon M, Chin-Hong PV, Miller SA, Chiu C, Damon L, Drew WL. Pandemic (H1N1) 2009 infection in patients with hematologic malignancy. Emerg Infect Dis 2010; 16:1910 - 7; http://dx.doi.org/10.3201/eid1612.100772; PMID: 21122221
   PubMed Web of Science ®Google Scholar
• Mazza JJ, Yale SH, Arrowood JR, Reynolds CE, Glurich I, Chyou PH, Linneman JG, Reed KD. Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res 2005; 3:214 - 20; http://dx.doi.org/10.3121/cmr.3.4.214; PMID: 16303886
   PubMedGoogle Scholar
• Monkman K, Mahony J, Lazo-Langner A, Chin-Yee BH, Minuk LA. The pandemic H1N1 influenza vaccine results in low rates of seroconversion for patients with hematological malignancies. Leuk Lymphoma 2011; 52:1736 - 41; http://dx.doi.org/10.3109/10428194.2011.584003; PMID: 21663502
   PubMed Web of Science ®Google Scholar
• Bate J, Yung CF, Hoschler K, Sheasby L, Morden J, Taj M, Heath PT, Miller E. Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom. Clin Infect Dis 2010; 51:e95 - 104; http://dx.doi.org/10.1086/657403; PMID: 21067352
   PubMedGoogle Scholar
• Brydak LB, Machała M, Centkowski P, Warzocha K, Biliński P. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma. Vaccine 2006; 24:6620 - 3; http://dx.doi.org/10.1016/j.vaccine.2006.05.100; PMID: 16870313
   PubMed Web of Science ®Google Scholar
• Porter CC, Edwards KM, Zhu Y, Frangoul H. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2004; 42:36 - 40; http://dx.doi.org/10.1002/pbc.10459; PMID: 14752792
   PubMed Web of Science ®Google Scholar
• Ljungman P, Avetisyan G. Influenza vaccination in hematopoietic SCT recipients. Bone Marrow Transplant 2008; 42:637 - 41; http://dx.doi.org/10.1038/bmt.2008.264; PMID: 18724396
   PubMed Web of Science ®Google Scholar
• Ljungman P, Nahi H, Linde A. Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Br J Haematol 2005; 130:96 - 8; http://dx.doi.org/10.1111/j.1365-2141.2005.05582.x; PMID: 15982350
   PubMed Web of Science ®Google Scholar
• Pollyea DA, Brown JM, Horning SJ. Utility of influenza vaccination for oncology patients. J Clin Oncol 2010; 28:2481 - 90; http://dx.doi.org/10.1200/JCO.2009.26.6908; PMID: 20385981
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May 2009. MMWR Morb Mortal Wkly Rep 2009; 58:497 - 500; PMID: 19444154
   PubMedGoogle Scholar
• Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009; 459:1122 - 5; http://dx.doi.org/10.1038/nature08182; PMID: 19516283
   PubMed Web of Science ®Google Scholar
• Mackay HJ, McGee J, Villa D, Gubbay JB, Tinker LM, Shi L, Kuruvilla J, Wang L, MacAlpine K, Oza AM. Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment. J Clin Virol 2011; 50:212 - 6; http://dx.doi.org/10.1016/j.jcv.2010.11.013; PMID: 21168361
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58:467 - 70; PMID: 19444150
   PubMedGoogle Scholar
• Gordon SM. Update on 2009 pandemic influenza A (H1N1) virus. Cleve Clin J Med 2009; 76:577 - 82; http://dx.doi.org/10.3949/ccjm.76a.05009; PMID: 19797457
   PubMed Web of Science ®Google Scholar
• Kao TM, Wang CH, Chen YC, Ko WJ, Chang SC. The first case of severe novel H1N1 influenza successfully rescued by extracorporeal membrane oxygenation in Taiwan. J Formos Med Assoc 2009; 108:894 - 8; http://dx.doi.org/10.1016/S0929-6646(09)60422-8; PMID: 19933034
   PubMed Web of Science ®Google Scholar
• Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361:2405 - 13; http://dx.doi.org/10.1056/NEJMoa0907413; PMID: 19745216
   PubMed Web of Science ®Google Scholar
• Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, Stephenson I. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009; 361:2424 - 35; http://dx.doi.org/10.1056/NEJMoa0907650; PMID: 19745215
   PubMed Web of Science ®Google Scholar
• Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, Zhu FC, Li RC, Xia SL, Zhao YL, Li FJ, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010; 375:56 - 66; http://dx.doi.org/10.1016/S0140-6736(09)62003-1; PMID: 20018364
   PubMed Web of Science ®Google Scholar
• Plennevaux E, Sheldon E, Blatter M, Reeves-Hoché MK, Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010; 375:41 - 8; http://dx.doi.org/10.1016/S0140-6736(09)62026-2; PMID: 20018365
   PubMed Web of Science ®Google Scholar
• Roman F, Vaman T, Gerlach B, Markendorf A, Gillard P, Devaster JM. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial. Vaccine 2010; 28:1740 - 5; http://dx.doi.org/10.1016/j.vaccine.2009.12.014; PMID: 20034605
   PubMed Web of Science ®Google Scholar
• Vajo Z, Tamas F, Sinka L, Jankovics I. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet 2010; 375:49 - 55; http://dx.doi.org/10.1016/S0140-6736(09)62039-0; PMID: 20018367
   PubMed Web of Science ®Google Scholar
• Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang XF, Zhang XF, Pan HX, Meng FY, Hu YM, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009; 361:2414 - 23; http://dx.doi.org/10.1056/NEJMoa0908535; PMID: 19846844
   PubMed Web of Science ®Google Scholar
• Hodges GR, Davis JW, Lewis HD Jr., Whittier FC Jr., Siegel CD, Chin TD, Clark GM, Noble GR. Response to influenza A vaccine among high-risk patients. South Med J 1979; 72:29 - 32; http://dx.doi.org/10.1097/00007611-197901000-00010; PMID: 366766
   PubMed Web of Science ®Google Scholar
• Mazza JJ, Yale SH, Arrowood JR, Reynolds CE, Glurich I, Chyou PH, Linneman JG, Reed KD. Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res 2005; 3:214 - 20; http://dx.doi.org/10.3121/cmr.3.4.214; PMID: 16303886
   PubMedGoogle Scholar
• Monkman K, Mahony J, Lazo-Langner A, Chin-Yee BH, Minuk LA. The pandemic H1N1 influenza vaccine results in low rates of seroconversion for patients with hematological malignancies. Leuk Lymphoma 2011; 52:1736 - 41; http://dx.doi.org/10.3109/10428194.2011.584003; PMID: 21663502
   PubMed Web of Science ®Google Scholar
• Bate J, Yung CF, Hoschler K, Sheasby L, Morden J, Taj M, Heath PT, Miller E. Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom. Clin Infect Dis 2010; 51:e95 - 104; http://dx.doi.org/10.1086/657403; PMID: 21067352
   PubMedGoogle Scholar
• Brydak LB, Machała M, Centkowski P, Warzocha K, Biliński P. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma. Vaccine 2006; 24:6620 - 3; http://dx.doi.org/10.1016/j.vaccine.2006.05.100; PMID: 16870313
   PubMed Web of Science ®Google Scholar
• Porter CC, Edwards KM, Zhu Y, Frangoul H. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2004; 42:36 - 40; http://dx.doi.org/10.1002/pbc.10459; PMID: 14752792
   PubMed Web of Science ®Google Scholar
• Ljungman P, Avetisyan G. Influenza vaccination in hematopoietic SCT recipients. Bone Marrow Transplant 2008; 42:637 - 41; http://dx.doi.org/10.1038/bmt.2008.264; PMID: 18724396
   PubMed Web of Science ®Google Scholar
• Ljungman P, Nahi H, Linde A. Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Br J Haematol 2005; 130:96 - 8; http://dx.doi.org/10.1111/j.1365-2141.2005.05582.x; PMID: 15982350
   PubMed Web of Science ®Google Scholar
• Pollyea DA, Brown JM, Horning SJ. Utility of influenza vaccination for oncology patients. J Clin Oncol 2010; 28:2481 - 90; http://dx.doi.org/10.1200/JCO.2009.26.6908; PMID: 20385981
   PubMed Web of Science ®Google Scholar
• Bedognetti D, Ansaldi F, Zanardi E, Durando P, Sertoli MR, Massucco C, Balleari E, Racchi O, Zoppoli G, Orsi A, et al. Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. Blood 2012; 120:1954 - 7; http://dx.doi.org/10.1182/blood-2012-06-438689; PMID: 22936740
   PubMed Web of Science ®Google Scholar
• Villa D, Gubbay J, Sutherland DR, Laister R, McGeer A, Cooper C, Fortuno ES 3rd, Xu W, Shi L, Kukreti V, et al. Evaluation of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies receiving chemotherapy or following autologous stem cell transplant. Leuk Lymphoma 2013; 54:1387 - 95; http://dx.doi.org/10.3109/10428194.2012.742524; PMID: 23240909
   PubMed Web of Science ®Google Scholar
• Yri OE, Torfoss D, Hungnes O, Tierens A, Waalen K, Nordøy T, Dudman S, Kilander A, Wader KF, Ostenstad B, et al. Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood 2011; 118:6769 - 71; http://dx.doi.org/10.1182/blood-2011-08-372649; PMID: 22058114
   PubMed Web of Science ®Google Scholar
• Hottinger AF, George AC, Bel M, Favet L, Combescure C, Meier S, Grillet S, Posfay-Barbe K, Kaiser L, Siegrist CA, et al, H1N1 Study Group. A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients. Oncologist 2012; 17:436 - 45; http://dx.doi.org/10.1634/theoncologist.2011-0342; PMID: 22357731
   PubMed Web of Science ®Google Scholar
• Takata T, Suzumiya J, Ishikawa T, Takamatsu Y, Ikematsu H, Tamura K. Attenuated antibody reaction for the primary antigen but not for the recall antigen of influenza vaccination in patients with non-Hodgkin B-cell lymphoma after the administration of rituximab-CHOP. J Clin Exp Hematop 2009; 49:9 - 13; http://dx.doi.org/10.3960/jslrt.49.9; PMID: 19474512
   PubMedGoogle Scholar
• Hirota Y, Kaji M, Ide S, Goto S, Oka T. The hemagglutination inhibition antibody responses to an inactivated influenza vaccine among healthy adults: with special reference to the prevaccination antibody and its interaction with age. Vaccine 1996; 14:1597 - 602; http://dx.doi.org/10.1016/S0264-410X(96)00153-3; PMID: 9032887
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Ohfuji S, Fukushima W, Maeda A, Maeda K, Fujioka M, Hirota Y. Immunogenicity and reactogenicity of a monovalent inactivated 2009 influenza A vaccine in adolescents: with special reference to pre-existing antibody. J Pediatr 2012; 160:632 - 7, e1; http://dx.doi.org/10.1016/j.jpeds.2011.09.055; PMID: 22094234
   PubMed Web of Science ®Google Scholar
• Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, Newman RA, Hanna N, Anderson DR. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 1994; 83:435 - 45; PMID: 7506951
   PubMed Web of Science ®Google Scholar
• Maloney DG, Liles TM, Czerwinski DK, Waldichuk C, Rosenberg J, Grillo-Lopez A, Levy R. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 1994; 84:2457 - 66; PMID: 7522629
   PubMed Web of Science ®Google Scholar
• Valentine MA, Meier KE, Rossie S, Clark EA. Phosphorylation of the CD20 phosphoprotein in resting B lymphocytes. Regulation by protein kinase C. J Biol Chem 1989; 264:11282 - 7; PMID: 2472394
   PubMed Web of Science ®Google Scholar
• Press OW, Appelbaum F, Ledbetter JA, Martin PJ, Zarling J, Kidd P, Thomas ED. Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood 1987; 69:584 - 91; PMID: 3492224
   PubMed Web of Science ®Google Scholar
• Bedognetti D, Zoppoli G, Massucco C, Zanardi E, Zupo S, Bruzzone A, Sertoli MR, Balleari E, Racchi O, Messina M, et al. Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin’s lymphoma patients treated with rituximab-containing regimens. J Immunol 2011; 186:6044 - 55; http://dx.doi.org/10.4049/jimmunol.1004095; PMID: 21498665
   PubMed Web of Science ®Google Scholar
• Organization WH. World Health Organization manual on animal influenza diagnosis and surveillance. Global Influenza Programme Geneva: WHO 2002.
   Google Scholar
• Spila-Alegiani S, Salmaso S, Rota MC, Tozzi AE, Raschetti R. Reactogenicity in the elderly of nine commercial influenza vaccines: results from the Italian SVEVA study. Study for the evaluation of adverse events of influenza vaccination. Vaccine 1999; 17:1898 - 904; http://dx.doi.org/10.1016/S0264-410X(98)00467-8; PMID: 10217587
   PubMed Web of Science ®Google Scholar
• Oculo-respiratory syndrome following influenza vaccination: review of post-marketing surveillance through four influenza seasons in Canada. Can Commun Dis Rep 2005; 31:217 - 25; PMID: 16669126
   PubMedGoogle Scholar
• Food and Drug Administration. 21 CFR Part 600.80. Postmarketing reporting of adverse experiences. Fed Regist 1997; 62:52252 - 3
   Google Scholar
• Ohfuji S, Fukushima W, Deguchi M, Kawabata K, Yoshida H, Hatayama H, Maeda A, Hirota Y. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination. J Infect Dis 2011; 203:1301 - 8; http://dx.doi.org/10.1093/infdis/jir026; PMID: 21459817
   PubMed Web of Science ®Google Scholar
• Guideline on influenza vaccines prepared from viruses with the potential to cause a pandemic and intended for use outside the core dossier context. 2007.
   Google Scholar